Avaleht › Eesnäärmevähk › Ohio › Cincinnati
Eesnäärmevähk kliinilised uuringud linnas Cincinnati, OH
18 uuringut haiguse Eesnäärmevähk jaoks otsivad osalejaid linnas Cincinnati ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- ja veel 3
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
VärbamineFaas 2
- Saint Elizabeth Healthcare Edgewood, Edgewood · 8 mi kaugusel
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
VärbamineFaas 3
- TriState Urologic Services PSC Inc. dba The Urology Group, Cincinnati
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
VärbamineFaas 3
- Oncology Hematology Care Incorporated, Cincinnati
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
VärbamineFaas 3
- Urology Group - Solaris Network, Cincinnati
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
VärbamineFaas 1
- Oncology Hematology Care Incorporated, Cincinnati
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
VärbamineFaas 2
- Solaris Health - The Urology Group, Cincinnati
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
VärbamineFaas 1
- Oncology Hematology Care Incorporated, Cincinnati
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
VärbamineFaas 3
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
VärbamineFaas 1
- University of Cincinnati Medical Center, Cincinnati
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
VärbamineFaas 3
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- ja veel 1
Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE)
VärbamineVaatlusuuring
- The University of Cinncinatti, Cincinnati
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
VärbamineFaas 2
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- ja veel 1
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
VärbamineFaas 3
- Oncology Hematology Care Inc-Kenwood, Cincinnati
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
VärbamineFaas 1/2
- Research Site 113, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
VärbamineVaatlusuuring
- Massive Bio SYNERGY-AI site, Cincinnati
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
VärbamineFaas 3
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi kaugusel
Real World Prostate Cancer Registry
VärbamineVaatlusuuring
- Cincinnati Cancer Advisors, Cincinnati
Eesnäärmevähk uuringud teistes linnades
- New York City, NY103 uuringut
- Houston, TX76 uuringut
- Los Angeles, CA61 uuringut
- Boston, MA59 uuringut
- St. Louis, MO46 uuringut
- Chicago, IL45 uuringut
- San Francisco, CA45 uuringut
- Philadelphia, PA44 uuringut
- Baltimore, MD43 uuringut
- Nashville, TN42 uuringut
- Seattle, WA42 uuringut
- Washington, DC38 uuringut
Muud uuringud linnas Cincinnati
- Mitteväikerakuline kopsuvähk35 uuringut
- Vähk (kõik liigid)27 uuringut
- Rinnavähk25 uuringut
- Südamepuudulikkus24 uuringut
- Käär- ja pärasoolevähk21 uuringut
- Äge müeloidne leukeemia20 uuringut
- Metastaatiline vähk20 uuringut
- Munasarjavähk19 uuringut
- Kopsuvähk19 uuringut
- Rasvumine19 uuringut
- Müeloom17 uuringut
- Melanoom17 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.